TMO vs ZBH
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | ZBH |
|---|---|---|
| Price | $700.22 | $103.21 |
| Market cap | $259.44B | $19.53B |
| P/E ratio | 36.9 | 26.1 |
| ROE | 13.38% | 6.03% |
| Profit margin | 14.94% | 8.95% |
| Revenue growth | 9.10% | 3.10% |
| Dividend yield | 0.27% | 0.93% |
| Beta | 0.84 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs ZBH in plain English
- TMO is the bigger company — about 13.3× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 26.1 vs 36.9).
- TMO earns a higher return on equity (13% vs 6%).
- TMO is growing revenue faster (9% vs 3%).
- ZBH has the higher dividend yield (0.93% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.